George Millen: Unscripted

In Las Vegas, IQSTEL is on a mission to woo institutional investors. With a massive acquisition and a new buyback, can it fix its valuation problem?

As AI incidents surge over 200%, a cyber resilience veteran is launching a command center to contain the chaos. It’s a new frontier of corporate risk.

A landmark deal between Trading Technologies and Kalshi is set to unlock prediction markets for institutional investors, leveraging advanced tools for a new era of risk management.

As the World Cup kicks off, 115 Chinese-made trains are Mexico's transit backbone. It's a high-stakes test of tech, a geopolitical play, and a PR coup.

CTS Corp's new TSX Crystal integrates a thermistor, a move targeting the multi-billion dollar precision timing market for 5G, auto, and medical tech.

A utility's summer water-saving tips are more than just advice; they're a signal of Illinois' precarious resource reality and a test of corporate strategy.

A record $1.15M campaign for blood cancer reveals a new playbook where executive influence, not just corporate checks, drives profound social impact.

As new federal work rules loom for Indiana's Medicaid members, MHS is investing millions in a workforce program. Is it a proactive lifeline or a new corporate playbook?

A guidance cut at Sanuwave reveals a deeper crisis in wound care, driven by CMS policy shifts that are fueling a disruptive secondary equipment market.

A new surgical method called SMART, developed at Delray Medical Center, uses biological scaffolds to overcome the failure of sutures in critical muscle injuries.

As Latus Bio advances its Huntington's therapy to clinic, new CBO Bethany Mancilla brings a history of high-value deals to fuel the company's growth.

Mars hits a 100% renewable US energy milestone, but is it a true blueprint for corporate climate action? A deep dive into the story behind the numbers.

Tiny biotech HCW Biologics reports promising early data for its alopecia drug. But with a small sample size and big pharma rivals, is this a true breakthrough?

Bruce Eaton's appointment as Chairman at Broken String isn't just a new hire; it's a strategic move to make its INDUCE-seq technology the industry's gold standard.

With a $240M user savings claim and top liquidity, MEXC's zero-fee model is a bold market play. But is it sustainable, and can its security promises hold up?

US innovator FlexPatio enters Australia's $48B reno market with a high-tech pergola. Is its DIY-friendly, storm-proof design the key to unlocking value?

The National Alliance on Mental Illness elects its 2027 board, blending proven leadership with powerful new voices defined by personal and professional insight.

A record $10M gift establishes a new research chair, honoring a titan of Canadian finance and positioning Montreal to solve the critical organ shortage.

A small-town medical spa is investing in cutting-edge tech for body, bladder, and brain. Is this the future of healthcare or a high-stakes gamble?

The leading director association's new hires in content and HR signal a strategic pivot, equipping boards for a landscape defined by AI, public trust, and human capital.